Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. - Wikidata - wikimedia - TriplyDB

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.

http://www.wikidata.org/entity/Q37135634

about

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants Novel oral anticoagulant management issues for the stroke clinician.Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.One decade of oral anticoagulation in stroke patients: Results from a large country-wide hospital-based registry.Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinc Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.

P2860

Q26750467-580BB9DF-D31C-45B3-8286-0B69641C6454 Q38910667-55D4DDCF-616E-4699-A3C1-A22ECB862C22 Q47281751-58CA294F-3811-419D-B039-CB77F0C5B8FD Q48282050-ED2E91E4-B245-45D4-AF26-FA61B9B33A5E Q48721021-264F29EA-B3BA-4D3F-BFD5-AE38588A83AB Q48870323-0DF26BB3-7B2A-4308-9AE3-220F89809F43 Q49850586-7523001C-1E42-42BC-A367-86A9AC5E84D5

P2860

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.

http://www.wikidata.org/entity/Q37135634

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 January 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Trends in oral anticoagulant c ...... Japan: the SAMURAI-NVAF study.

@en

Trends in oral anticoagulant c ...... Japan: the SAMURAI-NVAF study.

@nl

type

label

Trends in oral anticoagulant c ...... Japan: the SAMURAI-NVAF study.

@en

Trends in oral anticoagulant c ...... Japan: the SAMURAI-NVAF study.

@nl

prefLabel

Trends in oral anticoagulant c ...... Japan: the SAMURAI-NVAF study.

@en

Trends in oral anticoagulant c ...... Japan: the SAMURAI-NVAF study.

@nl

P1433

Q37135634-F8040312-E518-4753-8C35-48A76524F8A6

P1476

Q37135634-73426484-B84A-422C-839E-152FB5E817D0

P2093

Q37135634-0050D344-AEED-4478-B546-FA9E7D6B3337

Q37135634-02FA3451-CC43-46A5-A79C-F0337ED1C7EF

Q37135634-08B0BA9B-836C-4FC1-9D6D-B5A93F22859A

Q37135634-0E0656CA-C75B-4C44-80A3-0A1DC7D851AA

Q37135634-20E87306-B9EA-4C6E-ABDE-950514A3DF49

Q37135634-298F8D3F-DC93-461C-93C8-1D7756FEBF0C

Q37135634-47035296-560D-4DB2-8876-B407550311F6

Q37135634-588ADC53-A968-4934-BBDA-7D867F4E4C60

Q37135634-66C19A7D-36A4-4E1F-9883-37C5D387C0FC

Q37135634-751257C3-965B-4DBB-9342-1CF4B6790DF2

P2860

Q37135634-0BD871C1-E754-4CBE-BFC8-84155554EBC3

Q37135634-0C523407-5EFC-43D5-B0E3-78F61344A10C

Q37135634-1D55D40F-4104-4794-A9E6-41163889EC91

Q37135634-1E09D3E9-1422-41D5-9EE0-B50B87C158CF

Q37135634-20F1CB69-5927-4CD0-BDEE-C54B0ACE8298

Q37135634-35AF0859-003B-4E09-A368-53CEE7D67FFD

Q37135634-4732D64B-8591-431F-9DC6-297E47042460

Q37135634-4A0B48D9-3A65-441A-B511-42F5026EB500

Q37135634-510C17D4-6291-4099-A733-11922ED3F862

Q37135634-5DDDC1AF-389C-4079-B0DE-842769E830AF

P304

Q37135634-C31F3374-8F70-49E1-9846-7332EFE880D5

P31

Q37135634-ACC902E6-D306-44F4-9CF2-0988E71F7252

P356

Q37135634-2EE77E7F-5B41-427D-A41B-FEFC3CCC0A97

P433

Q37135634-FB2C5BD8-BC88-4186-A7CC-1C3F96017CBE

P478

Q37135634-7E79E411-D6AE-4F1E-A4EE-BAB84E624921

P50

Q37135634-6DF43FA5-5B75-4EEA-93AA-FA80FEF29E6F

P577

Q37135634-E83D2998-59E1-49AA-9EE3-BB12A8D277C2

P5875

Q37135634-B132FEA0-A8A1-4C9F-8295-FC16428AFA27

P698

Q37135634-98B7655F-E2A4-42CA-8E55-4CC57160311E

P921

Q37135634-29A73CDF-988D-4162-A71A-D2801F7EFDA7

Q37135634-C98C663D-F1B8-4C98-A3A3-BAD7C151EB25

P932

Q37135634-62B0BB00-ED1F-4941-ADA6-9FE2768A63FE

P356

P1433

International Journal of Stroke

P1476

Trends in oral anticoagulant c ...... Japan: the SAMURAI-NVAF study.

@en

P2093

Eisuke Furui

http://www.w3.org/2001/XMLSchema#string

Hiroshi Mochizuki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yamagami

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Takamatsu

http://www.w3.org/2001/XMLSchema#string

Kazumi Kimura

http://www.w3.org/2001/XMLSchema#string

Kazunori Toyoda

http://www.w3.org/2001/XMLSchema#string

Kazuomi Kario

http://www.w3.org/2001/XMLSchema#string

Kazutoshi Nishiyama

http://www.w3.org/2001/XMLSchema#string

Kenichi Todo

http://www.w3.org/2001/XMLSchema#string

Kenji Kamiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Dabigatran versus warfarin in patients with atrial fibrillation

Validation of Clinical Classification Schemes for Predicting Stroke

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Anticoagulation intensity of rivaroxaban for stroke patients at a special low dosage in Japan

P304

836-842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJS.12452

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270763893

http://www.w3.org/2001/XMLSchema#string

P698

25581108

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

atrial fibrillation

P932

4964913

http://www.w3.org/2001/XMLSchema#string